# OnCo record magnetismm-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/magnetismm-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "magnetismm-3", "NCT04649359" ;
  schema:name "MagnetisMM-3"@en ;
  schema:description "MagnetisMM-3 is the pivotal study behind elranatamab's approval."@en ;
  schema:url <https://onco.cc/trials/magnetismm-3/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04649359> ;
  onco:status "positive" ;
  onco:phase "2" ;
  schema:startDate "2021-02-02" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/elranatamab/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .